Evidence map›Paper›PMID 32683652›Full record

ArticleMolecular neurobiology2020

Tau Protein as a New Regulator of Cellular Prion Protein Transcription.

Laia Lidón, Cristina Vergara, Isidro Ferrer, Félix Hernández, Jesús Ávila, Jose A Del Rio, Rosalina Gavín

Abstract read
PubMed Publisher
In one paragraph

Article in Molecular neurobiology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.5field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 11 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. The multiple functions of PrPJournal of molecular medicine (Berlin, Germany) · 2022
    Review
  7. Article
  8. Tau Exon 10 Inclusion by PrPInternational journal of molecular sciences · 2021
    Article
  9. PrPFrontiers in molecular neuroscience · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Laia LidónMolecular and Cellular Neurobiotechnology, Institute for Bioengineering of Catalonia (IBEC), Scientific Park of Barcelona, The Barcelona Institute for Science and Technology (BIST), Baldiri and Reixac 15-21, 08028, Barcelona, Spain.
Cristina VergaraLaboratory of Histology, Neuroanatomy and Neuropathology, UNI (ULB Neuroscience Institute), Faculty of Medicine, Université Libre de Bruxelles, Brussels, Belgium.
Isidro FerrerNetwork Centre of Biomedical Research of Neurodegenerative Diseases (CIBERNED), Institute of Health Carlos III, Ministry of Economy and Competitiveness, Madrid, Spain.
Félix HernándezNetwork Centre of Biomedical Research of Neurodegenerative Diseases (CIBERNED), Institute of Health Carlos III, Ministry of Economy and Competitiveness, Madrid, Spain.
Jesús ÁvilaNetwork Centre of Biomedical Research of Neurodegenerative Diseases (CIBERNED), Institute of Health Carlos III, Ministry of Economy and Competitiveness, Madrid, Spain.
Jose A Del RioMolecular and Cellular Neurobiotechnology, Institute for Bioengineering of Catalonia (IBEC), Scientific Park of Barcelona, The Barcelona Institute for Science and Technology (BIST), Baldiri and Reixac 15-21, 08028, Barcelona, Spain. jadelrio@ibecbarcelona.eu.ORCID https://orcid.org/0000-0002-5214-4909
Rosalina GavínMolecular and Cellular Neurobiotechnology, Institute for Bioengineering of Catalonia (IBEC), Scientific Park of Barcelona, The Barcelona Institute for Science and Technology (BIST), Baldiri and Reixac 15-21, 08028, Barcelona, Spain. rgavin@ub.edu.ORCID https://orcid.org/0000-0003-1982-2162
Instituto de Salud Carlos III · ESBiomedical Research Networking Center on Neurodegenerative Diseases · ESUniversité Libre de Bruxelles · BE

Funding

ciberned PRY-2018-2Generalitat de Catalunya SGR2017-648"la Caixa" Foundation LCF/PR/HR19/52160007Ministerio de Ciencia, Innovación y Universidades RTI2018-099773-B-I00Spanish prion network AGL2017-90665-REDT
6 · The paper itself

Abstract

Cellular prion protein (PrP

Indexed as

Transcription, GeneticAmyloid beta-PeptidesAnimalsBinding SitesHEK293 CellsHumansLigandsMice, Inbred C57BLMice, TransgenicPrion ProteinsPromoter Regions, GeneticProtein Kinase InhibitorsReactive Oxygen SpeciesSolubilitytau ProteinsAmyloid beta-PeptidesLigandsPrion ProteinsProtein Kinase InhibitorsReactive Oxygen Speciestau ProteinsAlzheimer’s diseaseCellular prion proteinPromoterTauTauopathies

Identifiers

PMID32683652
OpenAlexW3043820660

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.